文献速递结核与非结核分枝杆菌艾滋病与性传播感染

南非HIV感染孕妇结核病预防性治疗的建模分析:临床获益与风险

Tuberculosis Preventive Treatment for Pregnant People With HIV in South Africa: A Modeling Analysis of Clinical Benefits and Risks.
PubMed 文献 · Clin Infect Dis · 2025-01-01

该微模拟模型评估南非接受抗逆转录病毒治疗的HIV感染孕妇5种结核病预防性治疗策略。若不良妊娠结局风险低于可识别阈值,孕期结核病预防性治疗可降低母婴合并死亡;鉴于异烟肼风险不确定性及较低阈值,需研究新型结核病预防性治疗方案以指导指南。

要点

  • 孕期结核病使死产和低出生体重的建模风险分别增加250%和81%。
  • 若立即结核病预防性治疗使死产或低出生体重增加低于4%或20%,其母婴合并死亡少于延迟治疗。
  • 鉴于异烟肼风险不确定及较低阈值,需研究新型结核病预防性治疗方案以指导指南。

核心结论

  • 若不良妊娠结局风险低于可识别阈值,孕期结核病预防性治疗可降低HIV感染孕妇的母婴合并死亡。
  • 鉴于异烟肼风险不确定及不良妊娠结局风险可超过避免结核死亡获益的较低阈值,需研究新型结核病预防性治疗方案以指导指南。

研究设计与样本

  • 使用微模拟模型评估南非接受抗逆转录病毒治疗的HIV感染孕妇的5种结核病预防性治疗策略:无结核病预防性治疗、孕期立即6个月异烟肼或3个月异烟肼-利福喷丁、产后延迟6个月异烟肼或3个月异烟肼-利福喷丁。
  • 主要结局为可能受结核病预防性治疗影响的孕产妇、胎儿/婴儿及合并死亡(孕产妇结核、孕产妇肝毒性、死产、低出生体重和婴儿结核)。

主要发现

  • 孕期结核病使死产和低出生体重的建模风险分别增加250%和81%。
  • 在较低风险或较高风险场景中,立即结核病预防性治疗使死产风险降低38%或升高92%,使低出生体重风险降低16%或升高35%。
  • 立即结核病预防性治疗将最小化HIV感染孕妇的死亡。
  • 当结核病预防性治疗带来较高死产和低出生体重风险时,即使孕产妇CD4细胞计数低和结核发病率高,立即结核病预防性治疗产生的母婴合并死亡最多。
  • 若立即结核病预防性治疗使死产或低出生体重增加低于4%或低于20%,立即结核病预防性治疗产生的合并死亡少于延迟结核病预防性治疗(敏感性分析范围分别为低于2%-22%和低于11%-120%)。

关键数值与推荐

  • 孕期结核病使死产风险增加250%,低出生体重风险增加81%。
  • 立即结核病预防性治疗在较低风险场景使死产风险降低38%、低出生体重风险降低16%,在较高风险场景使死产风险升高92%、低出生体重风险升高35%。
  • 若立即结核病预防性治疗使死产增加低于4%或使低出生体重增加低于20%,其合并死亡少于延迟治疗;敏感性分析范围分别为低于2%-22%和低于11%-120%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although prior studies of tuberculosis-preventive treatment (TPT) for pregnant people with human immunodeficiency virus (PPWH) report conflicting adverse pregnancy outcome (APO) risks, international guidelines recommend TPT for PPWH. METHODS: We used a microsimulation model to evaluate 5 TPT strategies among PPWH receiving antiretroviral therapy in South Africa: No TPT; 6 months of isoniazid (6H) or 3 months of isoniazid-rifapentine (3HP) during pregnancy (Immediate 6H or Immediate 3HP) or post partum (Deferred 6H or Deferred 3HP). The primary outcomes were maternal, fetal/infant, and combined deaths from causes potentially influenced by TPT (maternal tuberculosis, maternal hepatotoxicity, stillbirth, low birth weight [LBW], and infant tuberculosis). Tuberculosis during pregnancy confers 250% and 81% higher modeled risks of stillbirth and LBW, respectively. In lower-risk or higher-risk scenarios, immediate TPT confers 38% lower or 92% higher risks of stillbirth and 16% lower or 35% higher risks of LBW. RESULTS: Immediate TPT would minimize deaths among PPWH. When TPT confers higher stillbirth and LBW risks, immediate TPT would produce the most combined maternal and fetal/infant deaths, even with low maternal CD4 cell count and high tuberculosis incidence. If immediate TPT yields a <4% or <20% increase in stillbirth or LBW, immediate TPT would produce fewer combined deaths than deferred TPT (sensitivity analysis range, <2%-22% and <11%-120%, respectively). CONCLUSIONS: If APO risks are below identifiable thresholds, TPT during pregnancy could decrease combined maternal and fetal/infant deaths. Given uncertainty around isoniazid's risks, and the low threshold at which APO risks could outweigh benefits from tuberculosis deaths averted, studies of newer TPT regimens among PPWH are warranted to inform guidelines.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Rosen LV, Thielking AM, Dugdale CM, et al. Tuberculosis Preventive Treatment for Pregnant People With HIV in South Africa: A Modeling Analysis of Clinical Benefits and Risks. Clin Infect Dis. 2025. PMID: 39544107. doi:10.1093/cid/ciae508

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。